Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Return on Sales (2016 - 2025)

Traws Pharma (TRAW) has disclosed Return on Sales for 14 consecutive years, with 6.41% as the latest value for Q4 2025.

  • For Q4 2025, Return on Sales rose 8784.0% year-over-year to 6.41%; the TTM value through Dec 2025 reached 6.41%, up 62357.0%, while the annual FY2025 figure was 6.41%, 62357.0% up from the prior year.
  • Return on Sales hit 6.41% in Q4 2025 for Traws Pharma, down from 5.55% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.46% in Q2 2025 and bottomed at 2164.0% in Q2 2024.
  • Average Return on Sales over 5 years is 180.17%, with a median of 81.18% recorded in 2023.
  • Year-over-year, Return on Sales tumbled -208312bps in 2024 and then skyrocketed 216354bps in 2025.
  • Traws Pharma's Return on Sales stood at 67.2% in 2021, then tumbled by -52bps to 102.39% in 2022, then rose by 22bps to 79.68% in 2023, then decreased by -18bps to 94.25% in 2024, then surged by 93bps to 6.41% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 6.41%, 5.55%, and 0.46% for Q4 2025, Q3 2025, and Q2 2025 respectively.